Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$9.99 - $18.71 $2.6 Million - $4.87 Million
260,361 Added 33.49%
1,037,763 $19.2 Million
Q2 2023

Aug 14, 2023

BUY
$9.17 - $19.29 $384,351 - $808,521
41,914 Added 5.7%
777,402 $8.6 Million
Q1 2023

May 17, 2023

BUY
$12.53 - $21.71 $2.13 Million - $3.7 Million
170,303 Added 30.13%
735,488 $9.88 Million
Q4 2022

Mar 06, 2023

BUY
$11.61 - $16.11 $329,967 - $457,862
28,421 Added 5.29%
565,185 $6.99 Million
Q3 2022

Nov 02, 2022

BUY
$12.21 - $19.7 $208,082 - $335,727
17,042 Added 3.28%
536,764 $7.49 Million
Q2 2022

Aug 12, 2022

BUY
$11.23 - $19.59 $341,055 - $594,948
30,370 Added 6.21%
519,722 $7.18 Million
Q1 2022

May 13, 2022

BUY
$13.37 - $17.79 $1.35 Million - $1.8 Million
101,002 Added 26.01%
489,352 $7.96 Million
Q4 2021

Feb 14, 2022

BUY
$14.28 - $19.53 $731,264 - $1 Million
51,209 Added 15.19%
388,350 $6.33 Million
Q3 2021

Nov 12, 2021

BUY
$12.99 - $20.47 $2.06 Million - $3.25 Million
158,653 Added 88.89%
337,141 $5.01 Million
Q2 2021

Aug 10, 2021

BUY
$15.46 - $24.5 $2.76 Million - $4.37 Million
178,288 Added 89144.0%
178,488 $3.56 Million
Q1 2020

May 12, 2020

BUY
$48.35 - $118.68 $9,670 - $23,736
200 New
200 $13,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.